UNLABELLED: Peripheral blood mononuclear cells (PBMCs), i.e. lymphocytes, monocytes and macrophages are key players in the development of innate and adaptive immune responses. However, little is known about their properties in patients with acute stroke. EXPERIMENTAL PROCEDURES: We presently characterized the early time course of PBMC subpopulations in 19 patients with acute ischemic stroke and symptom onset below 6 h compared to 19 age-matched healthy subjects. Immediately after acute ischemic stroke, as well as 1 and 3 days thereafter, PBMC subpopulations (cluster of differentiation [CD]3+, CD14+, CD19+, CD68+) were isolated by magnetic bead system and the expression of proinflammatory (CD40, tumor necrosis factor-alpha [TNFalpha]), proapoptotic (caspase-3 [CPP32], poly(ADP-ribose) polymerase [PARP]) and adhesion relevant (CD38) genes was measured by quantitative polymerase chain reaction (PCR). Furthermore, besides routine parameters, plasma levels of oxidized low-density lipoproteins (oxLDL) were studied. RESULTS: In comparison to healthy subjects, patients revealed (i) twofold elevated plasma oxLDL concentrations, (ii) decreased (15%) blood cholesterol levels, and (iii) a 40% decrease in total number of lymphocytes. Furthermore, the majority of PBMC subpopulations revealed an increased expression of proinflammatory, proapoptotic or adhesion-relevant genes. Significant positive correlations were observed between expression of most of these genes in PBMCs and individual plasma oxLDL concentrations. CONCLUSION: Elevated expression of proinflammatory, proapoptotic and adhesion genes in subsets of PBMCs after ischemic stroke may contribute to an immunodepressive syndrome, possibly due to increased plasma oxLDL levels.
UNLABELLED: Peripheral blood mononuclear cells (PBMCs), i.e. lymphocytes, monocytes and macrophages are key players in the development of innate and adaptive immune responses. However, little is known about their properties in patients with acute stroke. EXPERIMENTAL PROCEDURES: We presently characterized the early time course of PBMC subpopulations in 19 patients with acute ischemic stroke and symptom onset below 6 h compared to 19 age-matched healthy subjects. Immediately after acute ischemic stroke, as well as 1 and 3 days thereafter, PBMC subpopulations (cluster of differentiation [CD]3+, CD14+, CD19+, CD68+) were isolated by magnetic bead system and the expression of proinflammatory (CD40, tumor necrosis factor-alpha [TNFalpha]), proapoptotic (caspase-3 [CPP32], poly(ADP-ribose) polymerase [PARP]) and adhesion relevant (CD38) genes was measured by quantitative polymerase chain reaction (PCR). Furthermore, besides routine parameters, plasma levels of oxidized low-density lipoproteins (oxLDL) were studied. RESULTS: In comparison to healthy subjects, patients revealed (i) twofold elevated plasma oxLDL concentrations, (ii) decreased (15%) blood cholesterol levels, and (iii) a 40% decrease in total number of lymphocytes. Furthermore, the majority of PBMC subpopulations revealed an increased expression of proinflammatory, proapoptotic or adhesion-relevant genes. Significant positive correlations were observed between expression of most of these genes in PBMCs and individual plasma oxLDL concentrations. CONCLUSION: Elevated expression of proinflammatory, proapoptotic and adhesion genes in subsets of PBMCs after ischemic stroke may contribute to an immunodepressive syndrome, possibly due to increased plasma oxLDL levels.
Authors: Kate Freeman; Anthony Brureau; Rajanikanth Vadigepalli; Mary M Staehle; Melanie M Brureau; Gregory E Gonye; Jan B Hoek; D Craig Hooper; James S Schwaber Journal: J Neuroinflammation Date: 2012-05-24 Impact factor: 8.322
Authors: Frank R Sharp; Glen C Jickling; Boryana Stamova; Yingfang Tian; Xinhua Zhan; DaZhi Liu; Beth Kuczynski; Christopher D Cox; Bradley P Ander Journal: J Cereb Blood Flow Metab Date: 2011-04-20 Impact factor: 6.200
Authors: Peter Kraft; Christiane Drechsler; Michael K Schuhmann; Ignaz Gunreben; Christoph Kleinschnitz Journal: Int J Mol Sci Date: 2015-10-23 Impact factor: 5.923
Authors: Sue-Jie Koo; Heidi M Spratt; Kizhake V Soman; Susan Stafford; Shivali Gupta; John R Petersen; Maria P Zago; Muge N Kuyumcu-Martinez; Allan R Brasier; John E Wiktorowicz; Nisha Jain Garg Journal: Int J Proteomics Date: 2016-08-18
Authors: Ryan C Turner; Brandon Lucke-Wold; Noelle Lucke-Wold; Alisa S Elliott; Aric F Logsdon; Charles L Rosen; Jason D Huber Journal: Int J Mol Sci Date: 2013-01-17 Impact factor: 5.923
Authors: A Greco; G F Macri; A Gallo; M Fusconi; A De Virgilio; G Pagliuca; C Marinelli; M de Vincentiis Journal: J Immunol Res Date: 2014-01-15 Impact factor: 4.818
Authors: Hajar Amini; Natasha Shroff; Boryana Stamova; Eva Ferino; Paulina Carmona-Mora; Xinhua Zhan; Preston P Sitorus; Heather Hull; Glen C Jickling; Frank R Sharp; Bradley P Ander Journal: Ann Clin Transl Neurol Date: 2020-08-12 Impact factor: 4.511